Sodium stibogluconate (ssg) & paromomycin combination compared to ssg for visceral leishmaniasis in east africa: A randomised controlled trial

PLoS Neglected Tropical Diseases

Volumn 6, Issue 6, 2012, Pages

  Musa, Ahmed ^a   Khalil, Eltahir ^a   Hailu, Asrat ^b   Olobo, Joseph ^c   Balasegaram, Manica ^d,e   Omollo, Raymond ^e   Edwards, Tansy ^f   Rashid, Juma ^g   Mbui, Jane ^g   Musa, Brima ^a   Abuzaid, Abuzaid Abdalla ^a   Ahmed, Osama ^a   Fadlalla, Ahmed ^h   El Hassan, Ahmed ^a   Mueller, Marius ^d   Mucee, Geoffrey ^g   Njoroge, Simon ^g   Manduku, Veronica ^g   Mutuma, Geoffrey ^g   Apadet, Lilian ^g   Lodenyo, Hudson ^g   Mutea, Dedan ^g   Kirigi, George ^g   Yifru, Sisay ⁱ   Mengistu, Getahun ^b   Hurissa, Zewdu ⁱ   Hailu, Workagegnehu ⁱ   Weldegebreal, Teklu ^j   Tafes, Hailemariam ^j   Mekonnen, Yalemtsehay ^b   Makonnen, Eyasu ^b   Ndegwa, Serah ^k   Sagaki, Patrick ^l   Kimutai, Robert ^e,g   Kesusu, Josephine ^e,g   Owiti, Rhoda ^e,g   Ellis, Sally ^e   Wasunna, Monique ^e,g   more..

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c MAKERERE UNIVERSITY   (Uganda)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

^e Drugs for Neglected Diseases initiative DNDi   (Switzerland)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^h UNIVERSITY OF GADARIF   (Sudan)

ⁱ UNIVERSITY OF GONDAR   (Ethiopia)

^j Arba Minch Hospital   (Ethiopia)

^k UNIVERSITY OF NAIROBI   (Kenya)

^l Amudat Hospital   (Uganda)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; PAROMOMYCIN; STIBOGLUCONATE SODIUM; ANTIMONY GLUCONATE; ANTIPROTOZOAL AGENT;

ADOLESCENT; ADULT; AFRICA; ANAPHYLACTIC SHOCK; ARTICLE; AUDIOMETRY; CARDIOTOXICITY; CHILD; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; EPISTAXIS; FEBRILE CONVULSION; FEMALE; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HEMOPERITONEUM; HEPATITIS A; HERPES ZOSTER; HUMAN; HYPERTRANSAMINASEMIA; INJECTION SITE PAIN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; OTITIS MEDIA; PANCREATITIS; PARASITE CLEARANCE; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRESCHOOL CHILD; PRIAPISM; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEPSIS; SIDE EFFECT; TREATMENT OUTCOME; TUBERCULOUS PERICARDITIS; VISCERAL LEISHMANIASIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG TOXICITY; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AFRICA, EASTERN; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; DRUG TOXICITY; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PAROMOMYCIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863644072     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001674     Document Type: Article

References (21)

1. Control of the Leishmaniases: Report of a meeting of the WHO expert committee on the control of Leishmaniases, Geneva, 22-26 March 2010 Switzerland World Health Organization.
2. World Health Organization (2007) Fifth Consultative Meeting on Leishmania/HIV Coinfection, Addis Ababa, Ethiopia, 20-22 March2007 Switzerland World Health Organization.
3. Reithinger R, Brooker S, Kolaczinski JH, (2007) Visceral leishmaniasis in eastern Africa-current status. Trans R Soc Trop Med Hyg 101: 1169-1170.
4. Rijal S, Chappuis F, Singh R, Boelaert M, Loutan L, et al. (2003) Sodium stibogluconate cardiotoxicity and safety of generics. Trans R Soc Trop Med Hyg 97: 597-598.
5. Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, et al. (2006) A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis 43: 357-364.
6. Sundar S, (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6: 849-854.
7. Croft SL, Sundar S, Fairlamb AH, (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19: 111-126.
8. Hamad SH, Khalil EAG, Musa AM, Younis BM, Elfaki MEE, El-Hassan AM, (2010) Leishmania donovani: Genetic diversity of isolates from Sudan characterized by PCR-based RAPD. Experimental parasitology 2010; 125 (4): 389-93.
9. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK, (2007) Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med 356: 2571-2581.
10. Chunge CN, Owate J, Pamba HO, Donno L, (1990) Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans R Soc Trop Med Hyg 84: 221-225.
11. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Zaniewski AE, et al. (2000) A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg 94: 429-431.
12. Melaku Y, Collin SM, Keus K, Gatluak F, Ritmeijer K, et al. (2007) Treatment of kala-azar in Southern Sudan using a 17 dasy regimen of Sodium Stibogluconate combined with Paromomycin: A retrospective comparison with 30-day Sodium Stibogluconate monotherapy. Am J Trop Med Hyg 77 (1): 2007, 89-94.
13. Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, et al. (2010) Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis 4: e709.
14. Musa AM, Younis B, Fadlalla A, Royce C, Balasegaram M, et al. (2010) Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study. PLoS Negl Trop Dis 4: e855.
15. Brown EG, Wood L, Wood S, (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20 (2): 109-17.
16. Kirkwood BR, Stern J, (2003) Essential Medical Statistics Blackwell Science Ltd.
17. StataCorp LP College Station Texas 77845 USA: 1996 [http://www.stata.com].
18. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J, (2007) Development of a WHO growth reference for school-aged children and adolescents. Bulletin of the World Health Organization 85: 660-7 WHO Child growth data and macros. Available:http://www.who.int/growthref/en/.
19. Jha TK, Olliaro P, Thakur CP, Kanyok TP, Singhania BL, et al. (1998) Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ 316: 1200-1205.
20. Sundar S, Olliaro PL, (2007) Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management. Ther Clin Risk Manag 3: 733-740.
21. Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. (2008) The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334-359.